Cortical tau load is associated with white matter hyperintensities
Cortical tau load is associated with white matter hyperintensities
复制标题
DOI:
10.1186/s40478-015-0240-0
复制
发表时间:
2015-09-30
影响因子:
7.1
通讯作者:
Attems, Johannes
中科院分区:
文献类型:
--
作者:
McAleese, Kirsty E.;Firbank, Michael;Attems, Johannes
Introduction: Cerebral white matter lesions (WML), visualized as white matter hyperintensities (WMH) on 12-weighted MRI, encompass structural damage and loss of integrity of the cerebral white matter (WM) and are commonly assumed to be associated with small vessel disease (SVD). However, it has been suggested that WM damage may also be the result of degenerative axonal loss that is secondary to cortical Alzheimer's disease (AD) pathologies i.e., hyperphosphorylated tau (HPT) and amylo d-beta (A). Here we investigate the influence of HPT, A13 and SVD on WIVIH severity.Results: 36 human post-mortem right fixed cerebral hemispheres (mean age 84.4 7.7 years; male: 16, female: 20) containing varying amounts of AD-pathology (AD: 23, controls: 13) underwent T2- weighted MRI with WIVIH assessed according to the age related white matter change scale (ARWMC). After dissection, using tissue samples from the frontal, temporal, parietal and occipital regions from the right hemisphere, we quantitatively assessed cortical HPT and A beta pathology burden by measuring the percentage area covered by A18 immunoreactivity (HPT-IR) and 4G8 immunoreactivity (A beta-IR), and assessed the severity of WM SVD by calculating the sclerotic index (SI) of WM arteries/arterioles. HPT-IR, A beta-IR, and SI were compared with ARWMC scores. HPT-beta R, and WM ARWMC scores were all significantly higher in AD cases compared to controls, while SI values were similar between groups. ARWMC scores correlated with HPT-IR, A beta-IR and SI in various regions, however, linear regression revealed that only HPT-IR was a significant independent predictor of ARWMC scores.Conclusions: Here we have shown that increasing cortical HPT burden independently predicted the severity of WMH indicating its potentially important role in the pathogenesis of WM damage. Moreover, our findings suggest that in AD patients the presence of WMH may indicate cortical AD-associated pathology rather than SVD. Further studies are warranted to elucidate the pathological processes that lead to WM damage and to clarify if WMH may serve as a general biomarker for cortical AD-associated pathology.